{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-145194","form_type":"8-K","ticker":"IRWD","cik":"0001446847","company_name":"IRONWOOD PHARMACEUTICALS INC","filed_at":"2021-12-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.613385+00:00","generated_at":"2026-06-28T04:25:49.581423+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ironwood appoints Sravan Emany as CFO, effective Dec 6, 2021","bullets":["Sravan K. Emany named SVP, CFO effective Dec 6, 2021; Jason Rickard remains COO.","Emany previously corporate VP at Integra LifeSciences and managing director at BofA.","Base salary $500k, bonus target 50% of base, $200k sign-on bonus, 85k RSUs and 85k PSUs.","Emany to enter indemnification and executive severance agreement (filed as Exhibit 10.1)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-145194","json":"https://secwatch.observer/filing/0001104659-21-145194.json","markdown":"https://secwatch.observer/filing/0001104659-21-145194.md","text":"https://secwatch.observer/filing/0001104659-21-145194.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446847/000110465921145194/0001104659-21-145194-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446847/000110465921145194/tm2134154d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T04:25:49.581423+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d2bd4315c4","claim":"Sravan K. Emany was appointed as Senior Vice President, Chief Financial Officer at IRONWOOD PHARMACEUTICALS INC.","evidence_excerpt":"On November 29, 2021, the Board of Directors of Ironwood Pharmaceuticals, Inc. (the “Company”) appointed Sravan K. Emany, 44, as the Company’s Senior Vice President, Chief Financial Officer, effective December 6, 2021 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465921145194/0001104659-21-145194-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}